We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Novavax Inc | NASDAQ:NVAX | NASDAQ | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.19 | 4.03% | 4.90 | 4.77 | 5.00 | 4.94 | 4.6895 | 4.84 | 4,668,267 | 05:00:08 |
GAITHERSBURG, Md., Aug. 02, 2016 (GLOBE NEWSWIRE) -- Novavax, Inc. (Nasdaq:NVAX), a clinical-stage vaccine company focused on the discovery, development and commercialization of recombinant nanoparticle vaccines and adjuvants, today announced it will report its second quarter 2016 financial and operating results after the close of U.S. financial markets on Tuesday, August 9, 2016.
Management will host a conference call to discuss the quarterly financial results and provide an update on corporate activities.
Conference call details are as follows:
Date: | Tuesday, August 9, 2016 | |
Time: | 4:30 p.m. U.S. Eastern Time (ET) | |
Dial-in number: | (877) 212-6076 (Domestic) or (707) 287-9331 (International) | |
Passcode: | 59901631 | |
Via web: | www.novavax.com, "Investors"/ "Events" | |
Conference call replay:
Date: | Starting at 7:30 p.m. ET, August 9, 2016 until August 16, 2016 | |
Dial-in number: | (855) 859-2056 (Domestic) or (404) 537-3406 (International) | |
Passcode: | 59901631 | |
Via web: | www.novavax.com, "Investors"/ "Events" | |
About Novavax
Novavax, Inc. (Nasdaq:NVAX) is a clinical-stage vaccine company committed to delivering novel products to prevent a broad range of infectious diseases. Its recombinant nanoparticles and Matrix-M(TM) adjuvant technology are the foundation for groundbreaking innovation that improves global health through safe and effective vaccines.
Contact:
Novavax, Inc.
Barclay A. Phillips
SVP, Chief Financial Officer and Treasurer
Andrea N. Flynn, Ph.D.
Senior Manager, Investor Relations
ir@novavax.com
240-268-2000
1 Year Novavax Chart |
1 Month Novavax Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions